Cadila Healthcare informs about press release

18 Nov 2015 Evaluate

Cadila Healthcare has informed about a Press Release dated November 18, 2015 titled ‘Zydus announces clinical trials of Saroglitazar in patients with Severe Hypertriglyceridemia in USA’.

The above information is a part of company’s filings submitted to BSE.

 

Zydus Lifesciences Share Price

906.50 1.65 (0.18%)
16-Feb-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1695.50
Dr. Reddys Lab 1267.40
Cipla 1350.00
Zydus Lifesciences 906.50
Lupin 2220.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×